The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of ...

There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...

Over the late fall and into the winter, the Eastern Bluebird mural has been taking shape on the side of the 4 Girls And A ...

The successful trials come after Starlink rival AST SpaceMobile also used its newly launched satellites to power a video call ...

(NASDAQ:BLUE – Get Free Report) had its target price dropped by analysts at Wells Fargo & Company from $40.00 to $5.00 in a ...

The facility, which opened just over one year ago, has been involved in more than 350 calls to Boulder police since January ...

Wild Pink will never be mistaken for Spinal Tap, but the New York City band’s penchant for sprinkling some sarcasm throughout ...

Cymande at the Bluebird Theater article by Geoff Anderson, published on February 26, 2025 at All About Jazz. Find more Live Review articles ...

Lafayette Consolidated Government’s Traffic, Roads, and Bridges Department has planned a traffic signal outage at Camellia ...

Bluebird Bio, Inc. (NASDAQ:BLUE), on Friday, entered into a definitive agreement to be acquired by global investment firms ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global ...

Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle and SK Capital Partners at a discount, ending ...